Regional Differences in Antithrombotic Treatment for Atrial Fibrillation: Insights from the GLORIA-AF Phase II Registry
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Regional Differences in Antithrombotic Treatment for Atrial Fibrillation: Insights from the GLORIA-AF Phase II Registry ; volume:117 ; number:12 ; year:2017 ; pages:2376-2388
Thrombosis and haemostasis ; 117, Heft 12 (2017), 2376-2388
- Beteiligte Personen und Organisationen
-
Mazurek, Michał
Huisman, Menno V.
Rothman, Kenneth J.
Paquette, Miney
Teutsch, Christine
Diener, Hans-Christoph
Dubner, Sergio J.
Halperin, Jonathan L.
Ma, Chang Sheng
Zint, Kristina
Elsaesser, Amelie
Lu, Shihai
Lip, Gregory Y. H.
- DOI
-
10.1160/TH17-08-0555
- URN
-
urn:nbn:de:101:1-2018102807434428224727
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Mazurek, Michał
- Huisman, Menno V.
- Rothman, Kenneth J.
- Paquette, Miney
- Teutsch, Christine
- Diener, Hans-Christoph
- Dubner, Sergio J.
- Halperin, Jonathan L.
- Ma, Chang Sheng
- Zint, Kristina
- Elsaesser, Amelie
- Lu, Shihai
- Lip, Gregory Y. H.
Ähnliche Objekte (12)
Managing high-risk atrial fibrillation patients with multiple comorbidities
Are atrial high rate episodes (AHREs) a precursor to atrial fibrillation?
Management of Device Detected Subclinical Atrial Fibrillation
Real world time trends in antithrombotic treatment for newly diagnosed atrial fibrillation in China: reports from the GLORIA-AF Phase III registry : Trends in antithrombotic therapy use in China
Validation of the modified Microlife blood pressure monitor in patients with paroxysmal atrial fibrillation
Patients' Perceptions of Atrial Fibrillation, Stroke Risk, and Oral Anticoagulation Treatment: An International Survey
The effect of hypertension on cerebrovascular carbon dioxide reactivity in atrial fibrillation patients
The optimal antithrombotic strategy for post-stroke patients with atrial fibrillation and extracranial artery stenosis—a nationwide cohort study
Time in target range of systolic blood pressure and clinical outcomes in atrial fibrillation patients: results of the COOL-AF registry
Impact of early ablation of atrial fibrillation on long-term outcomes: results from phase II/III of the GLORIA-AF registry
Introducing Our New Offspring Journal … TH Open
Editors' Choice in the 60th Anniversary Year of Thrombosis and Haemostasis: Past, Present and Future
Managing high-risk atrial fibrillation patients with multiple comorbidities
Are atrial high rate episodes (AHREs) a precursor to atrial fibrillation?
Management of Device Detected Subclinical Atrial Fibrillation
Real world time trends in antithrombotic treatment for newly diagnosed atrial fibrillation in China: reports from the GLORIA-AF Phase III registry : Trends in antithrombotic therapy use in China
Validation of the modified Microlife blood pressure monitor in patients with paroxysmal atrial fibrillation
Patients' Perceptions of Atrial Fibrillation, Stroke Risk, and Oral Anticoagulation Treatment: An International Survey
The effect of hypertension on cerebrovascular carbon dioxide reactivity in atrial fibrillation patients
The optimal antithrombotic strategy for post-stroke patients with atrial fibrillation and extracranial artery stenosis—a nationwide cohort study
Time in target range of systolic blood pressure and clinical outcomes in atrial fibrillation patients: results of the COOL-AF registry
Impact of early ablation of atrial fibrillation on long-term outcomes: results from phase II/III of the GLORIA-AF registry
Introducing Our New Offspring Journal … TH Open
Editors' Choice in the 60th Anniversary Year of Thrombosis and Haemostasis: Past, Present and Future
Managing high-risk atrial fibrillation patients with multiple comorbidities
Are atrial high rate episodes (AHREs) a precursor to atrial fibrillation?
Management of Device Detected Subclinical Atrial Fibrillation
Real world time trends in antithrombotic treatment for newly diagnosed atrial fibrillation in China: reports from the GLORIA-AF Phase III registry : Trends in antithrombotic therapy use in China
Validation of the modified Microlife blood pressure monitor in patients with paroxysmal atrial fibrillation
Patients' Perceptions of Atrial Fibrillation, Stroke Risk, and Oral Anticoagulation Treatment: An International Survey
The effect of hypertension on cerebrovascular carbon dioxide reactivity in atrial fibrillation patients
The optimal antithrombotic strategy for post-stroke patients with atrial fibrillation and extracranial artery stenosis—a nationwide cohort study
Time in target range of systolic blood pressure and clinical outcomes in atrial fibrillation patients: results of the COOL-AF registry
Impact of early ablation of atrial fibrillation on long-term outcomes: results from phase II/III of the GLORIA-AF registry
Introducing Our New Offspring Journal … TH Open